Worldwide evaluation of Clinical Practice Strategies (CliPS) for lung involvement in Still's disease within the JIR-CliPS network: a COST action
- PMID: 40901639
- PMCID: PMC12401577
- DOI: 10.1093/rap/rkaf073
Worldwide evaluation of Clinical Practice Strategies (CliPS) for lung involvement in Still's disease within the JIR-CliPS network: a COST action
References
-
- Erkens RGA, Calis JJA, Verwoerd A et al. Recombinant interleukin‐1 receptor antagonist is an effective first‐line treatment strategy in new‐onset systemic juvenile idiopathic arthritis, irrespective of HLA‐DRB1 background and IL1RN variants. Arthritis Rheumatol 2024;76:119–29. - PubMed
-
- Ruscitti P, Berardicurti O, Iacono D et al. Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients. Arthritis Res Ther 2020;22:151. - PMC - PubMed
LinkOut - more resources
Full Text Sources